ORBIMED ADVISORS LLC – Protara Therapeutics, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$2.45M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+1.02%
quarter
Protara Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 25K | $2.96 | 830.64K | |
| Q2 2022 | share | 0.00% | 0 shares | -1.81M | $2.93 | 830.64K | |
| Q1 2022 | share | 0.00% | 0 shares | -1.36M | $5.11 | 830.64K | |
| Q4 2021 | share | Increase | +84.59% | 380.64K shares | 2.49M | $6.54 | 830.64K |
| Q3 2021 | share | 0.00% | 0 shares | -1.26M | $6.92 | 450K | |
| Q2 2021 | share | 0.00% | 0 shares | -2.7M | $9.74 | 450K | |
| Q1 2021 | share | 0.00% | 0 shares | -3.81M | $15.74 | 450K | |
| Q4 2020 | share | 0.00% | 0 shares | 3.32M | $24.21 | 450K | |
| Q3 2020 | share | Increase | 0.00% | 450K shares | 7.57M | $16.83 | 450K |